136 Views
Sunday Poster Session
Category: Colorectal Cancer Prevention
Melanie N. Cabezas, MD
Duke University
Durham, NC, United States
Question/Statement | Pre-Intervention | Post-Intervention | |||
Mean (SD) | N | Mean (SD) | N | p-value* | |
How confident are you in: | |||||
Identifying a comprehensive list of patients in your panel who are not up-to-date on colon cancer screening | 2.82 (1.10) | 50 | 3.43 (1.07) | 35 | 0.009 |
Identifying the available colon cancer screening options available in your current clinical practice | 3.16 (0.82) | 50 | 3.80 (0.90) | 35 | < 0.001 |
Discussing options for colon cancer screening with patients and participating in shared decision making to assist patients in selecting the most appropriate option for them | 3.42 (0.84) | 50 | 3.82 (0.82) | 35 | 0.046 |
For the following, how confident are you in recommending guideline-based colon cancer screening and follow-up: | |||||
FOBT | 2.95 (0.77) | 49 | 3.34 (0.94) | 35 | 0.044 |
Cologuard | 2.63 (0.78) | 49 | 3.31 (0.99) | 35 | < 0.001 |
Colonoscopy | 4.2 (0.71) | 49 | 4.46 (0.51) | 35 | 0.118 |
For the following, how confident are you in predicting and assisting patients in overcoming potential barriers to successful completion: | |||||
FOBT | 2.68 (0.82) | 50 | 3.29 (0.86) | 35 | 0.002 |
Cologuard | 2.48 (0.74) | 50 | 3.14 (0.88) | 35 | < 0.001 |
Colonoscopy | 3.46 (1.01) | 50 | 3.74 (0.82) | 35 | 0.214 |